How does PC4d aid in the prediction of future thrombotic events in those with SLE? And how can it be utilized by clinicians to help their lupus patients?

Join Exagen and Dr. Anca Askanase, founder and clinical director of Columbia’s new Lupus Center and the director of Rheumatology Clinical Trials, as she breaks down the abstract, Role of PC4d in Predicting Risk of Thrombotic Events in SLE, how the study came to be, and its clinical importance to both providers and patients.